Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward.
0/5 보강
APA
Toro-Tobon D, Singh Ospina N, Brito JP (2025). Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward.. Thyroid : official journal of the American Thyroid Association, 35(1), 3-5. https://doi.org/10.1089/thy.2024.0690
MLA
Toro-Tobon D, et al.. "Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward.." Thyroid : official journal of the American Thyroid Association, vol. 35, no. 1, 2025, pp. 3-5.
PMID
39772719 ↗
같은 제1저자의 인용 많은 논문 (5)
- The Prediction Paradox: AI, Genetics, and Occult Metastasis in Thyroid Cancer.
- Evaluating the Total Healthcare Cost of Inappropriately Ordered Thyroid Ultrasounds.
- Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers.
- Controversies in the Management of Intermediate-Risk Differentiated Thyroid Cancer.
- Artificial Intelligence in Thyroidology: A Narrative Review of the Current Applications, Associated Challenges, and Future Directions.